Pharmaceutical & Health Care Archives - Page 13 of 14 - Modern Distribution Management

Latest In Pharmaceutical & Health Care

The quarter ended June 30, 2009 provided positive earnings results for major pharmaceutical distributors Owens & Minor, McKesson Corp. and AmerisourceBergen.
Second quarter sales for Owens & Minor, Richmond, VA, were $2.01 billion, an increase of 13.7% over the same period a year ago. Profit was flat in the year over year comparison at $23.6 million.

Year-to-date, Owens & Minor sales were $3.96 billion, up 13.3% from the first half of 2008. Profit decreased 21.4% to $37.6 million, due in part to charges associated with exiting the direct-to-consumer business during the first quarter.

San Francisco, CA-based McKesson’s fiscal year 2010 first quarter sales were flat with first quarter 2008 sales at $26.7 billion. Profit improved 23% to $288 million.
Sales for …

Drug distributor Cardinal Health, Dublin, OH, says that when it spins off its Clinical and Medical Products businesses later this year it will reduce its global workforce by 800 over six months and eliminate an additional 500 positions through normal attrition and not filling open roles. The distributor also plans to implement cost control measures and reductions in discretionary spending.
 
The actions are in response to a "delay in hospital capital spending" specifically, and the decline in the global economy generally, according a press release.
 
Cardinal said back in January that the spending delay is only a "temporary concern," according to an article at WSJ.com.
 
Cardinal Health, Inc. is a $91 billion global …

Columbus McKinnon Corp., Amherst, NY, designer, manufacturer and marketer of material handling products, reported sales of $165.1 million for the third quarter of fiscal 2009 ended Dec. 28, 2008, up 12.9% over the prior-year same period. Profit was down 61.8% to $3.8 million.

Reported quarterly results include the acquisition of Pfaff-silberblau that closed on Oct. 1, 2008. One-time accounting adjustments related to the acquisition, higher material costs, lower sales volume of the higher margin pre-Pfaff businesses, and restructuring charges affected fiscal 2009 third quarter income from operations.

Sales for the first nine months of fiscal 2009 were $470.9 million, up 8.9% compared with the first nine months of fiscal 2008 and up 2.7% excluding the Pfaff …

Evolution was the force behind the decision to spin-off one of drug distributor Cardinal Health’s two divisions, according to CEO Kerry Clark in an article that appeared in Columbus Business First. The spinoff -announced in September -is expected to be completed by June.
 
The restructuring turned an organization that was operating as several different companies under one umbrella into a more cohesive organization. The split made sense based on the two focuses: The Healthcare Supply Chain Services distributes drugs and supplies; Clinical and Medical Products researches and produces infusion pumps and drug-dispensing systems.
 
 “The …

Owens &Minor, Richmond, VA, has agreed to sell its direct-to-consumer, diabetes supply business to Liberty Healthcare Group, Inc. for $63 million in cash. The assets include patient data and intellectual property.

The transaction is expected to close in early January.

Owens &Minor, Inc. is a distributor of name-brand medical and surgical supplies and a healthcare supply-chain management …

McKesson Corp., San Francisco, CA, has reached an agreement to settle damage claims  of inflated prices on prescription drugs paid by private health-benefit plans and individuals. The company has agreed to pay $350 million. With the settlement, the drug distributor continues to deny the claims made in the lawsuit.
 
The terms are subject to final court approval.
 
The company will also record a reserve for outstanding and expected future claims by public entities, which is estimated to be $143 million.
 
As we have consistently stated, we believe the plaintiffs’allegations are without merit, and that McKesson adhered to all applicable laws,”said John H. Hammergren, CEO. “Yet when faced with the inherent uncertainty of this litigation, we determined …

Owens & Minor, Richmond, VA, reported sales of $1.81 billion for the third quarter ended Sept. 30, 2008, up 7.3% from the third quarter of 2007. Profit increased 19.4% to $25.3 million.
 
For the nine months ended Sept. 30, sales were $5.36 billion, an increase of 6.1% in a year-over-year comparison. Profit improves 45.5% to $73.1 million.
 
Owens &Minor, Inc., is a distributor of national name-brand medical and surgical supplies and a healthcare supply-chain management company. …

Cardinal Health, Dublin, OH, drug and medical products distributor, reported an 11% increase in revenue to $24 billion for the quarter ended Sept. 30, 2008, driven by strong sales in the Healthcare Supply Chain Services segment and continued growth within Clinical and Medical Products.
 
The Healthcare Supply Chain Services segment achieved double-digit revenue growth, which helped partially offset the expected year-over-year profit decline from previously disclosed contract re-pricings and anti-diversion efforts for controlled substances.
 
The company performed as expected with double-digit revenue and profit performance from Clinical and Medical Products, and I am encouraged by continued signs of early progress in the pharmaceutical supply chain business,”said …

Drug distributor McKesson Corp., San Francisco, CA, reported sales for the second quarter ended Sept. 30, 2008, were $26.6 billion, a 9% increase over the prior year. Profit improved 32% to $327 million.
 
Year-to-date, sales increased 9% in a year-over-year comparison to $53.3 billion. The company reported profit for the period of $562 million, an increase of 17%.
 
In the Distribution Solutions segment, sales grew 9%. U.S. pharmaceutical direct distribution and services revenues grew 16% for the quarter, while warehouse sales were down 7%. Canadian revenues increased 15% due to new and expanded distribution agreements, market growth rates, and one additional day of sales. Medical-Surgical distribution revenues were up 9% for the quarter.
 
In Technology …

Walgreen Co., Deerfield, IL, has agreed to acquire Atlanta, GA-based McKesson Corp.’s specialty pharmacy operations, a business within McKesson’s Specialty division. The acquisition includes the McKesson specialty pharmacy in Pittsburgh, PA, and IVPCARE based in Frisco, TX, with operations in Torrence, CA, Wilmington, MA, and St. Louis, MO. Terms of the agreement were not disclosed.
 
The acquisition of McKesson’s specialty pharmacy operations offers the opportunity to grow our own specialty pharmacy business with preferred payor agreements,” said Stanley B. Blaylock, president of Walgreens Health Services. “This transaction will broaden access for patients and clients in the fast-growing oncology area and other specialty areas including multiple sclerosis, rheumatoid …

Just three months after restructuring, drug distributor Cardinal Health, Dublin, OH, has announced that it will be spinning of its newly focused Clinical and Medical Products segment into a standalone medical technology business. The new public company will be based in San Diego, CA.
 
David L. Schlotterbeck, currently vice chairman of Cardinal, has been tapped as CEO of the as-yet unnamed company. George S. Barrett, who currently heads the Healthcare Supply Chain Services, will succeed R. Kerry Clark as CEO of Cardinal. Clark will retire after the spin-off.
 
Since 1996, Cardinal Health has built an industry-leading med-tech business that, as an independent company, would have the size and scale to stand on its own,” Clark said. “This strategic decision will benefit …

Owens &Minor, Richmond, VA-based distributor of medical and surgical supplies, has agreed to acquire The Burrows Company, a Chicago-based, privately-held distributor of medical and surgical supplies to the acute-care market. Owens &Minor will pay $30.2 million for The Burrows Company, which reported 2007 sales of $603 million.
 
The acquisition of The Burrows Company, a large regional distributor with more than 75 years of experience in the acute-care market, is a strong geographic fit for Owens &Minor,” said Craig R. Smith, president and CEO of Owens &Minor.
 
Owens &Minor will launch a conversion process designed to transition The Burrows Company customers to Owens &Minor’s systems by the end the second quarter of …

Dublin, OH-based drug distributor Cardinal Health, reported revenue for fiscal year 2008 improved 5% to $91 billion over the prior year. Profit was $1.3 billion, a 32% decrease from fiscal year 2007. Earnings for the year were negatively impacted by a $600 million expense to resolve securities litigation.
 
For the fourth quarter, sales were $22.9 billion, an increase of 3% in a year-over-year comparison. Profit was $326.6 million, a decrease of 64% from fourth quarter 2007.
 
The medical supply chain segment improved profit in the second half of the year, driven by double-digit growth in its core U.S. medical distribution business. Combined revenue for the Clinical Technologies and Services, and Medical Products and Technologies segments grew by 24% to $5.6 billion …

Owens &Minor, Richmond, VA, reported revenue for the second quarter ended June 30, 2008, was $1.79 billion, up 6.9% from the prior-year period. Profit was $23.6 million, an increase of 29%.
 
For the six months ended June 30, 2008, revenue was $3.55 billion, up 5.4%. Profit for the first half was $47.8 million, up …

Two drug distributors announced increased revenues for their quarters ending June 30, 2008.
 
San Francisco, CA-based McKesson Corp. reported first-quarter revenues of $26.7 billion, an increase of 9% over the same period a year ago. Profit remained stable at $235 million.
 
In the Distribution Solutions segment, U.S. pharmaceutical revenues increased 16% while warehouse sales declined 8% for the quarter. Canadian revenues were up 27%, primarily due to new and expanded distribution contracts and a favorable currency impact of 10%. Medical-Surgical distribution revenues were up 6% for the quarter.
 
Technology Solutions had a revenue increase of 2% for the quarter.
 
AmerisourceBergen, Valley Forge, PA, announced revenue for third quarter 2008 …

Medical product and drug distributor Cardinal Health, Dublin, OH, is restructuring to cut costs and realign resources.
 
With the changes the company reduces its workforce by 600 positions. Of those positions, 160 are open and will not be filled.
 
Cardinal’s network of pharmaceutical and medical product distribution centers and nuclear pharmacies will form the Healthcare Supply Chain Services segment, which will have revenues of more than $80 billion.
 
Products for infusion, medication dispensing, respiratory care and infection prevention will be grouped in the Clinical and Medical Products segment with annual revenue of $5 billion.
 
Through this restructuring, we sharpen our focus on two distinct, large and growing segments of the health …

Bloomberg reports that drug wholesaler McKesson Corp. will likely settle damage claims of as much as $15 billion for inflating prices on prescription drugs paid by private health-benefit plans and individuals. McKesson has more than $100 billion in annual revenues. The drug distributor has denied the claims made in the lawsuit. The Bloomberg article offers good background on the case. Read it here.
 
Related articles from MDM:
McKesson May Face Treble Damages in Class Action

San Francisco, CA-based McKesson Corp. has agreed to buy McQueary Brothers Drug Company, a Springfield, MO-based regional distributor of pharmaceutical, health, and beauty products to more than 400 independent and regional chain pharmacies in Missouri, Arkansas, Illinois, Kansas, Oklahoma, Nebraska and Iowa.
 
The acquisition expands McKesson’s distribution footprint in the Midwestern U.S. and continues momentum in the independent pharmacy segment. The purchase price is $190 million.
 
McQueary Brothers will be integrated into McKesson’s U.S. Pharmaceutical business, which is reported in the McKesson Distribution Solutions segment. …

3M Canada, a wholly-owned subsidiary of St. Paul, MN-based 3M, has acquired Les Entreprises Solumed Inc., a Quebec-based developer and marketer of medical products designed to prevent infections in operating rooms and hospitals.
 
Solumed brings a chlorhexidine gluconate (CHG) and alcohol-based line of products to 3M’s offering for infection prevention. The addition of Solumed positions 3M for growth in the fast-growing segment of intravenous (IV) site care and in preoperative care and hand hygiene, where CHG-based products are gaining momentum,”said Chuck Kummeth, vice president and general manager, 3M Medical Division.
 
Solumed’s products such as antiseptic wipes and swabsticks, along with surgical scrub brush-sponges and antiseptic gels, complement 3M’s existing …

Register for full access

By providing your email, you agree to receive announcements from us and our partners for our newsletter, events, surveys, and partner resources per MDM Terms & Conditions. You can withdraw consent at any time.

Learn More about Custom Reports

Request a Market Prospector Demo

  • This field is for validation purposes and should be left unchanged.

Get the MDM Update Newsletter

Wholesale distribution news and trends delivered right to your inbox.

Sign-up for our free newsletter and get:

  • Up-to-date news in a quick-to-read format
  • Free access to webcasts, podcasts and live events
  • Exclusive whitepapers, research and reports
  • And more!